|
TCP11L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.915370E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.638500E-03 |
| Normal-vs-Stage2 |
8.68530000031065E-07 |
| Normal-vs-Stage3 |
4.471700E-02 |
| Normal-vs-Stage4 |
2.079400E-01 |
| Stage1-vs-Stage2 |
1.404280E-03 |
| Stage1-vs-Stage3 |
9.097000E-01 |
| Stage1-vs-Stage4 |
5.248000E-01 |
| Stage2-vs-Stage3 |
4.402800E-03 |
| Stage2-vs-Stage4 |
4.821700E-03 |
| Stage3-vs-Stage4 |
6.852000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.728380E-02 |
| Normal-vs-AfricanAmerican |
8.166400E-01 |
| Normal-vs-Asian |
5.660100E-03 |
| Caucasian-vs-AfricanAmerican |
2.759800E-01 |
| Caucasian-vs-Asian |
2.692600E-01 |
| AfricanAmerican-vs-Asian |
7.621500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.762800E-04 |
| Normal-vs-Female |
6.659400E-03 |
| Male-vs-Female |
1.881210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.401170E-01 |
| Normal-vs-Age(41-60Yrs) |
3.799500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.958960E-03 |
| Normal-vs-Age(81-100Yrs) |
1.172010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.511650E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.050100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.617800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.039200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.887400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.568400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.305400E-01 |
| Classical-VS-Follicular |
1.95800042845917E-11 |
| Classical-VS-Other |
6.425900E-02 |
| Classical-VS-Normal |
1.167630E-01 |
| Tall-VS-Follicular |
4.808200E-04 |
| Tall-VS-Other |
8.222200E-02 |
| Tall-VS-Normal |
7.556000E-01 |
| Follicular-VS-Other |
8.322800E-01 |
| Follicular-VS-Normal |
3.99460020616971E-10 |
| Other-VS-Normal |
5.000400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80069999999866E-06 |
| Normal-vs-N1 |
1.019450E-01 |
| N0-vs-N1 |
1.839920E-02 |
|
|
